Pembrolizumab With Chemotherapy in Front Line Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Clinical trial NCT03410784 · UNKNOWN
Trial details
- NCT number
- NCT03410784
- Sponsor
- National Cancer Institute, Naples
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-01
- Primary completion
- 2024-08-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.